Please use this identifier to cite or link to this item:
Title: Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice
Authors: Xiang, W. 
Ke, Z. 
Zhang, Y. 
Ho-Yuet Cheng, G.
Irwan, I.D.
Sulochana, K.N. 
Potturi, P. 
Wang, Z.
Yang, H.
Wang, J.
Zhuo, L.
Kini, R.M. 
Ge, R. 
Keywords: Angiogenesis
Issue Date: Feb-2011
Citation: Xiang, W., Ke, Z., Zhang, Y., Ho-Yuet Cheng, G., Irwan, I.D., Sulochana, K.N., Potturi, P., Wang, Z., Yang, H., Wang, J., Zhuo, L., Kini, R.M., Ge, R. (2011-02). Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice. Journal of Cellular and Molecular Medicine 15 (2) : 359-374. ScholarBank@NUS Repository.
Abstract: Anti-angiogenesis represents a promising therapeutic strategy for the treatment of various malignancies. Isthmin (ISM) is a gene highly expressed in the isthmus of the midbrain-hindbrain organizer in Xenopus with no known functions. It encodes a secreted 60 kD protein containing a thrombospondin type 1 repeat domain in the central region and an adhesion-associated domain in MUC4 and other proteins (AMOP) domain at the C-terminal. In this work, we demonstrate that ISM is a novel angiogenesis inhibitor. Recombinant mouse ISM inhibited endothelial cell (EC) capillary network formation on Matrigel through its C-terminal AMOP domain. It also suppressed vascular endothelial growth factor (VEGF)-basic fibroblast growth factor (bFGF) induced in vivo angiogenesis in mouse. It mitigated VEGF-stimulated EC proliferation without affecting EC migration. Furthermore, ISM induced EC apoptosis in the presence of VEGF through a caspase-dependent pathway. ISM binds to αvβ5 integrin on EC surface and supports EC adhesion. Overexpression of ISM significantly suppressed mouse B16 melanoma tumour growth through inhibition of tumour angiogenesis without affecting tumour cell proliferation. Knockdown of isthmin in zebrafish embryos using morpholino antisense oligonucleotides led to disorganized intersegmen-tal vessels in the trunk. Our results demonstrate that ISM is a novel endogenous angiogenesis inhibitor with functions likely in physiological as well as pathological angiogenesis. © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Source Title: Journal of Cellular and Molecular Medicine
ISSN: 15821838
DOI: 10.1111/j.1582-4934.2009.00961.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 13, 2021


checked on Jan 13, 2021

Page view(s)

checked on Jan 17, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.